↓ Skip to main content

Dove Medical Press

Article Metrics

Benefit–risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty

Overview of attention for article published in Vascular Health and Risk Management, March 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (79th percentile)
  • High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

policy
1 policy source
twitter
3 tweeters
facebook
1 Facebook page

Citations

dimensions_citation
20 Dimensions

Readers on

mendeley
78 Mendeley
Title
Benefit–risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty
Published in
Vascular Health and Risk Management, March 2014
DOI 10.2147/vhrm.s54714
Pubmed ID
Authors

Bennett Levitan, Zhong Yuan, Alexander G G Turpie, Richard J Friedman, Martin Homering, Jesse A Berlin, Scott D Berkowitz, Rachel B Weinstein, Peter M DiBattiste

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 78 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Colombia 1 1%
Slovenia 1 1%
Unknown 76 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 14 18%
Student > Bachelor 13 17%
Student > Postgraduate 9 12%
Student > Ph. D. Student 8 10%
Other 6 8%
Other 19 24%
Unknown 9 12%
Readers by discipline Count As %
Medicine and Dentistry 56 72%
Pharmacology, Toxicology and Pharmaceutical Science 4 5%
Nursing and Health Professions 2 3%
Agricultural and Biological Sciences 2 3%
Unspecified 1 1%
Other 3 4%
Unknown 10 13%

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 March 2018.
All research outputs
#2,842,468
of 12,680,099 outputs
Outputs from Vascular Health and Risk Management
#100
of 536 outputs
Outputs of similar age
#39,364
of 189,768 outputs
Outputs of similar age from Vascular Health and Risk Management
#3
of 22 outputs
Altmetric has tracked 12,680,099 research outputs across all sources so far. Compared to these this one has done well and is in the 77th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 536 research outputs from this source. They receive a mean Attention Score of 3.7. This one has done well, scoring higher than 81% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 189,768 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 79% of its contemporaries.
We're also able to compare this research output to 22 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.